Skip to content
MedsAcross

Medicine

Enalapril 1 mg/mL oral solution

Enalapril · Oral
Available on requestPrescription onlyUS FDA Cold chainGeneric name

Enalapril 1 mg/mL oral solution is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store refrigerated (2° to 8°C/36° to 46°F) in a tightly closed container…

Key facts

Active ingredient (INN)
Enalapril
Brand
Sold under the generic name
Strength
1 mg/mL
Dosage form
Oral solution
Route
Oral
Packs
150 mL, 1 bottle and 4 more
Manufacturers
Ascend LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaAmneal Pharmaceuticals NYBionpharmaNorthStar RxLLCWilshire Pharmaceuticals
Origin register
US FDA, United States
Storage
Store refrigerated (2° to 8°C/36° to 46°F) in a tightly closed container. Protect from freezing and excessive heat. Patients may store enalapril maleate oral solution at room temperature (20° to 25°C/68° to 77°F) for up to 60 days.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C09AA02 Enalapril
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2019
Identifiers
RxCUI 1435624DailyMed set ID 337707cc-4ed9-4121-bfff-c5015e5eca9d, b63bdaa6-b57b-417b-9a79-29f1fd5bbf08, c7934b45-eb6b-44c1-bd2c-ef0fa10850c1 +4NDC 59651-529, 31722-020, 52536-401 +4Application ANDA216458, ANDA214467, NDA208686 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
150 mL in 1 bottle67877-712-81Ascend LaboratoriesIndia5 September 2022
1 bottle in 1 carton / 150 mL in 1 bottle59651-529-55Aurobindo PharmaIndia8 January 2024
1 bottle in 1 carton / 150 mL in 1 bottle31722-020-15Camber PharmaceuticalsIndia14 February 2022
1 bottle in 1 carton / 150 mL in 1 bottle69238-1729-7Amneal Pharmaceuticals NY1 December 2019
1 bottle in 1 carton / 150 mL in 1 bottle69452-237-46Bionpharma11 August 2021
1 bottle in 1 carton / 150 mL in 1 bottle52536-401-01Wilshire Pharmaceuticals8 April 2024
1 bottle in 1 carton / 150 mL in 1 bottle72603-247-01NorthStar RxLLC1 May 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 December 1985Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Enalapril 1 mg/mL oral solution.

Compare 1

Other strengths and forms of Enalapril

Clinical summary

Enalapril is an angiotensin converting enzyme inhibitor indicated for the treatment of hypertension. It is available as tablets and oral solution. MedsAcross supplies Enalapril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Enalapril

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Enalapril 1 mg/mL oral solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.